Mechanisms underlying myxomatous valve disease
粘液瘤性瓣膜疾病的机制
基本信息
- 批准号:10611524
- 负责人:
- 金额:$ 52.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAdultAffectAllelesCardiac Surgery proceduresCause of DeathCellsCessation of lifeChildCiliaCollagen FiberCongenital Heart DefectsCoupledDataDepositionDevelopmentDiseaseElderlyEmbryoEndothelial CellsEnvironmentExhibitsExtracellular MatrixFBN1FoundationsFrequenciesGeneral PopulationGenerationsGenesGeneticGenetic EpistasisGenetic Predisposition to DiseaseGlycosaminoglycansHeartHeart AbnormalitiesHomeostasisHumanImmuneInfiltrationKnock-outKnockout MiceMacrophageMaintenanceMammalsMethodsMitral ValveMitral Valve ProlapseModelingMolecularMorbidity - disease rateMusMutationMyocardial dysfunctionNatureNeonatalOperative Surgical ProceduresOrthologous GenePopulationProteinsRegulationRoleSideSignal TransductionT-LymphocyteTestingTherapeuticTissuesTransgenic OrganismsTretinoinVertebratesWorkZebrafishapoAI regulatory protein-1cardiogenesiscell typeearly onseteffective therapyextracellularhealingimmune cell infiltrateimprovedloss of functionmechanotransductionmortalitymouse modelmutantneutrophilnovelolder patientpharmacologicpostnatalpreventreconstructionsingle-cell RNA sequencingtranscription factortranscriptome sequencingtranscriptomicsvalve replacement
项目摘要
Project Summary/Abstract
Myxomatous degeneration leads to mitral valve prolapse, which occurs in almost 3% of the general population
and 10% of the elderly, is a significant cause of morbidity and mortality. Additionally, early-onset of myxomatous
mitral valve degeneration is associated with both syndromic and non-syndromic diseases, supporting there is an
underlying genetic etiology. Despite the frequency of mitral valve diseases, the cellular, molecular, and genetic
etiologies underlying myxomatous degeneration of the mitral valves remain poorly understood. Presently, valve
reconstruction and replacement surgeries are the only therapies available for mitral valve diseases. Thus, in
order to develop novel non-invasive pharmacological therapies that can effectively prevent and ameliorate mitral
valve diseases, it is essential to understand conserved mechanisms the underlie the progression of valve
diseases in vertebrates. The specific aims of this proposal are to interrogate the mechanisms by which loss of
the Nr2f transcription factors can lead to the development of myxomatous valves in zebrafish and mice.
Numerous studies have indicated that mutations in Nr2f genes in humans are associated with a spectrum of
congenital heart defects, some of which are correlated with myxomatous valve degeneration. While requirements
for Nr2f factors are well-established in heart development, previous work has not implicated Nr2f transcription
factors in homeostasis of mature valves and myxomatous valve degeneration. Interestingly, the majority of
previous genes associated with myxomatous valve degeneration are involved in the regulation of extracellular
matrix, mechanotransduction, and cilia. Our preliminary analysis in adult zebrafish mutants called acorn worm
(aco), which are deficient for Nr2f1a, show they develop myxomatous atrioventricular valves with all the hallmarks
of myxomatous valves in mammals. Furthermore, we identify Nr2f proteins are expressed in previously
unrecognized populations of cells within the atrioventricular valves. In Aim 1, we will use tissue-specific rescue
and knockout approaches in zebrafish and mice to determine if valve endothelial cells require Nr2f to maintain
valve homeostasis and prevent myxomatous generation. In Aim 2, we will employ pharmacological and genetic
epistasis to decipher if RA and signals including Fibrillin 1, whose misexpression is associated with myxomatous
degeneration in humans, function downstream of Nr2f1a to promote myxomatous atrioventricular valve
degeneration. In Aim 3, we will use lineage tracing and ablation studies to determine if specific immune cells
contribute to the progression of myxomatous atrioventricular valves in aco mutants. Our use of these unique
mutants with complementary analysis in mice will dramatically improve our understanding of conserved
mechanisms that can lead to the progression of myxomatous valve degeneration in vertebrates. Ultimately, our
studies may provide the foundation for novel non-invasive therapies that can prevent and heal myxomatous
mitral valves in humans.
项目摘要/摘要
粘液瘤样变性导致二尖瓣脱垂,约占总人口的3%。
和10%的老年人,是发病率和死亡率的重要原因。此外,早发性粘液瘤
二尖瓣退行性变既与综合征性疾病有关,也与非综合征性疾病有关,支持有
潜在的遗传病因学。尽管二尖瓣疾病的频率很高,但细胞、分子和遗传因素
二尖瓣粘液瘤样变性的病因尚不清楚。目前,阀门
重建和置换手术是治疗二尖瓣疾病的唯一方法。因此,在
为开发有效预防和改善二尖瓣病变的新型非侵入性药物
对于瓣膜疾病,了解瓣膜进展的保守机制是至关重要的。
脊椎动物中的疾病。这项提议的具体目的是询问造成损失的机制
Nr2f转录因子可导致斑马鱼和小鼠的粘液瘤瓣膜发育。
大量研究表明,人类Nr2f基因突变与一系列
先天性心脏缺陷,其中一些与粘液瘤性瓣膜变性有关。虽然要求
由于Nr2f因子在心脏发育中得到了很好的证实,以前的工作并没有涉及Nr2f转录
影响成熟瓣膜动态平衡和粘液瘤性瓣膜退变的因素。有趣的是,大多数人
先前与粘液瘤性瓣膜变性相关的基因参与了细胞外的调节
基质、机械转导和纤毛。我们对成年斑马鱼突变体橡子虫的初步分析
(ACO)缺乏Nr2f1a,表明他们发展为粘液瘤房室瓣膜,具有所有特征
哺乳动物的粘液瘤瓣膜。此外,我们还鉴定了Nr2f蛋白在以前的
房室瓣膜内未被识别的细胞群。在目标1中,我们将使用组织特异性救援
斑马鱼和小鼠的基因敲除方法确定瓣膜内皮细胞是否需要Nr2f来维持
瓣膜动态平衡和防止粘液瘤的产生。在目标2中,我们将使用药理学和遗传学
破译类风湿性关节炎和包括纤维蛋白1在内的信号的上位性,其错误表达与粘液瘤相关
人类退行性变,Nr2f1a下游功能促进粘液瘤房室瓣
退化。在目标3中,我们将使用谱系追踪和消融研究来确定特定的免疫细胞
在ACO突变型粘液瘤型房室瓣的进展中起重要作用。我们使用这些独特的
在小鼠身上进行互补分析的突变体将极大地提高我们对保守序列的理解
可导致脊椎动物粘液瘤瓣膜退行性变的机制。最终,我们的
研究可能为预防和治愈粘液瘤的新的非侵入性疗法提供基础
人类的二尖瓣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua Waxman其他文献
Joshua Waxman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua Waxman', 18)}}的其他基金
Mechanisms governing the differentiation and maintenance of atrial identity
心房特性分化和维持的机制
- 批准号:
10676430 - 财政年份:2023
- 资助金额:
$ 52.34万 - 项目类别:
Molecular mechanisms of atrial development and regeneration
心房发育和再生的分子机制
- 批准号:
9363356 - 财政年份:2017
- 资助金额:
$ 52.34万 - 项目类别:
Molecular Mechanisms of Atrial Development and Regeneration
心房发育和再生的分子机制
- 批准号:
10601607 - 财政年份:2017
- 资助金额:
$ 52.34万 - 项目类别:
Coup-tf dependent mechanisms of ventricular and hemangioblast specification
心室和成血管细胞规范的 Coup-tf 依赖性机制
- 批准号:
8435042 - 财政年份:2013
- 资助金额:
$ 52.34万 - 项目类别:
Coup-tf dependent mechanisms of ventricular and hemangioblast specification
心室和成血管细胞规范的 Coup-tf 依赖性机制
- 批准号:
8819146 - 财政年份:2013
- 资助金额:
$ 52.34万 - 项目类别:
Coup-tf dependent mechanisms of ventricular and hemangioblast specification
心室和成血管细胞规范的 Coup-tf 依赖性机制
- 批准号:
8606886 - 财政年份:2013
- 资助金额:
$ 52.34万 - 项目类别:
Coup-tf dependent mechanisms of ventricular and hemangioblast specification
心室和成血管细胞规范的 Coup-tf 依赖性机制
- 批准号:
9031127 - 财政年份:2013
- 资助金额:
$ 52.34万 - 项目类别:
Elucidation of molecular networks required to limit cardiac cell number
阐明限制心肌细胞数量所需的分子网络
- 批准号:
8111233 - 财政年份:2010
- 资助金额:
$ 52.34万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 52.34万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 52.34万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 52.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 52.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 52.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)